Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1985 Oct;22(4):651–653. doi: 10.1128/jcm.22.4.651-653.1985

Persistence of Inoue-Melnick virus and antibody in cerebrospinal fluid.

J L Melnick, E Seidel, S S Wang, G Muchinik, E J Rashti, L D Jacobs, A I Freeman, J O'Malley
PMCID: PMC268485  PMID: 4077970

Abstract

Serial cerebrospinal fluid samples were obtained from 14 multiple sclerosis patients over a period of several months and were tested under code for Inoue-Melnick virus. In five of the positive patients, virus was present in 28 of 32 specimens collected over a period of 2 to 5 months. Four patients, from whom a total of 34 specimens were taken, yielded only a single isolate each. Five patients contributed 28 specimens, all of which were negative. In six patients (three virus positive and three virus negative), neutralizing antibody was detected in serum and in cerebrospinal fluid.

Full text

PDF
651

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Inoue Y. K., Nishibe Y., Melnick J. L. Classification of Inoue-Melnick virus into three antigenic types. J Clin Microbiol. 1984 Jul;20(1):118–119. doi: 10.1128/jcm.20.1.118-119.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Inoue Y. K., Nishibe Y., Nakamura Y. Virus associated with S.M.O.N. in Japan. Lancet. 1971 Apr 24;1(7704):853–854. doi: 10.1016/s0140-6736(71)91513-3. [DOI] [PubMed] [Google Scholar]
  3. Jacobs L., O'Malley J., Freeman A., Ekes R. Intrathecal interferon reduces exacerbations of multiple sclerosis. Science. 1981 Nov 27;214(4524):1026–1028. doi: 10.1126/science.6171035. [DOI] [PubMed] [Google Scholar]
  4. Melnick J. L., Seidel E., Inoue Y. K., Nishibe Y. Isolation of virus from the spinal fluid of three patients with multiple sclerosis and one with amyotrophic lateral sclerosis. Lancet. 1982 Apr 10;1(8276):830–833. doi: 10.1016/s0140-6736(82)91876-1. [DOI] [PubMed] [Google Scholar]
  5. Melnick J. L., Seidel E., Wang S. S., Muchinik G. Isolation of Inoue-Melnick virus and detection of antibodies in coded cerebrospinal fluid specimens from patients with disorders of the central nervous system. J Clin Microbiol. 1985 May;21(5):698–701. doi: 10.1128/jcm.21.5.698-701.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Melnick J. L., Wang S. S., Seidel E., Muchinik G., Zhang L. B., Lanford R. E. Characterization of IM virus, which is frequently isolated from cerebrospinal fluid of patients with multiple sclerosis and other chronic diseases of the central nervous system. J Virol. 1984 Dec;52(3):739–744. doi: 10.1128/jvi.52.3.739-744.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Norrby E. Viral antibodies in multiple sclerosis. Prog Med Virol. 1978;24:1–39. [PubMed] [Google Scholar]
  8. Ramirez-Lassepas M., Quinones M. R. Heparin therapy for stroke: hemorrhagic complications and risk factors for intracerebral hemorrhage. Neurology. 1984 Jan;34(1):114–117. doi: 10.1212/wnl.34.1.114. [DOI] [PubMed] [Google Scholar]
  9. Vartdal F., Vandvik B. Multiple sclerosis: subclasses of intrathecally synthesized IgG and measles and varicella zoster virus IgG antibodies. Clin Exp Immunol. 1983 Dec;54(3):641–647. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES